CSF1R and breast carcinoma: Another study revealed that pharmacological blockade of CSF-1/CSF-1R targeted specifically breast cancer CD11b+ Ly6Gneg Ly6Clow F4/80+ TAMs and induced increase in CD8+ lymphocyte infiltration [101].